April 2, 2020
by Guest Post
0 comments
IBM’s World Community Grid hosts Scripps Research project to help scientists virtually screen chemical compounds that might help fight COVID-19 NEW YORK –IBM (NYSE: IBM) today announced that anyone in the world with a PC, laptop or Mac and an … Continue reading
June 28, 2018
by Guest Post
0 comments
According to ADrugRehab.org, “Addiction is tricky and calculating, and it’s the only disease that can take more than one person down with it, if it is left unchallenged. Addiction dramatically alters the lives of not just the addicted person, but … Continue reading
February 13, 2018
by Guest Post
0 comments
UCLA researchers develop improved technique for creating brain tissue from stem cells UCLA researchers have developed an improved technique for creating simplified human brain tissue from stem cells. Because these so-called “mini brain organoids” mimic human brains in how they … Continue reading
August 17, 2017
by Guest Post
0 comments
Mouse study helps explain the paradoxical pro-cancer effects of paclitaxel COLUMBUS, Ohio – The very same treatment that thwarts breast cancer has a dark side – it can fuel the spread of the disease to the lungs.
March 25, 2017
by Guest Post
0 comments
In a “bad news, good news” scenario, researchers at North Carolina State University have found that some black sludge growing in a water-treatment site could have redeeming benefits.
February 9, 2017
by Guest Post
0 comments
Researchers from North Carolina State University and the National Institutes of Health (NIH) have developed a method that stops allergic reactions by removing a key receptor from mast cells and basophils. Their work has implications for the treatment of skin … Continue reading
January 31, 2017
by Guest Post
0 comments
Researchers in Japan, Hong Kong and U.S. launch crowdsourced research effort using IBM’s World Community Grid TOKYO, Japan; HONG KONG, China & HARTFORD, United States – 31 Jan 2017: Medical researchers and IBM (NYSE: IBM) are asking for the public’s … Continue reading
January 24, 2017
by Guest Post
0 comments
A new non-surgical treatment for low-risk prostate cancer can effectively kill cancer cells while preserving healthy tissue, reports a new UCL-led phase III clinical trial in 413 patients. The trial was funded by STEBA Biotech which holds the commercial license … Continue reading